Comparative activity of newer beta-lactam/beta-lactamase inhibitor combinations against Pseudomonas aeruginosa from patients hospitalized with pneumonia in European medical centers in 2020
Comparative activity of newer beta-lactam/beta-lactamase inhibitor combinations against Pseudomonas aeruginosa from patients hospitalized with pneumonia in European medical centers in 2020. by Sader HS, Carvalhaes CG, Shortridge D and Castanheira M. published in Eur. J. Clin. Microbiol. Infect. Dis. 2022; 41 (2): 319-324
